Scarica l'app Stockscreener
19.73
0.41%
0.08
Dopo l'orario di chiusura:
19.73
Precedente Chiudi:
$19.65
Aprire:
$19.54
Volume 24 ore:
225.00K
Relative Volume:
0.76
Capitalizzazione di mercato:
$542.88M
Reddito:
$320.35M
Utile/perdita netta:
$-75.01M
Rapporto P/E:
-8.237
EPS:
-2.3953
Flusso di cassa netto:
$-113.17M
1 W Prestazione:
+0.61%
1M Prestazione:
+6.36%
6M Prestazione:
+41.03%
1 anno Prestazione:
-10.24%
Intervallo 1D:
$19.38
$19.86
Intervallo di 1 settimana:
$19.04
$20.34
Portata 52W:
$13.46
$31.04
Fulgent Genetics Inc Stock (FLGT) Company Profile
Nome
Fulgent Genetics Inc
Settore
Industria
Telefono
626-350-0537
Indirizzo
4399 SANTA ANITA AVE, EL MONTE
Compare FLGT vs TMO, DHR, NTRA, IQV, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
19.73 | 548.10M | 320.35M | -75.01M | -113.17M | -2.3953 |
TMO
Thermo Fisher Scientific Inc
|
613.78 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
207.66 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
328.18 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
267.77 | 42.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
A
Agilent Technologies Inc
|
150.86 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-05 | Aggiornamento | UBS | Neutral → Buy |
| 2023-12-07 | Iniziato | UBS | Neutral |
| 2022-12-08 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-11-18 | Iniziato | Raymond James | Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-02-04 | Ripresa | Piper Sandler | Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Underperform |
| 2021-01-08 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2020-11-24 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-08-20 | Iniziato | Oppenheimer | Outperform |
| 2020-05-29 | Iniziato | BTIG Research | Buy |
| 2019-11-05 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2018-03-01 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2017-11-07 | Downgrade | Raymond James | Outperform → Mkt Perform |
Mostra tutto
Fulgent Genetics Inc Borsa (FLGT) Ultime notizie
Hsieh Ming Surrenders 4,392 Shares of Fulgent Genetics at $19.59 Each - Kalkine Media
Fulgent Genetics CFO Kim Paul Surrenders 2,087 Shares at $19.59 Each - Kalkine Media
Fulgent Genetics president and COO Xie Jian sells $41,809 in stock By Investing.com - Investing.com South Africa
FLGT Q2 2026 Earnings: Wider-Than-Expected Loss of -$0.58 Pressures SharesEarnings Revision Downgrade - vinanet.vn
Fulgent Genetics CSO Hanlin Gao sells $32,885 in stock By Investing.com - Investing.com South Africa
Fulgent Genetics CSO Hanlin Gao sells $32,885 in stock - Investing.com India
Fulgent Genetics (NASDAQ:FLGT) COO Sells 2,127 Shares - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Insider Sells $32,891.18 in Stock - MarketBeat
Fulgent Genetics (FLGT) officer plans stock sale to cover taxes - Stock Titan
BlackRock Inc. Makes New $46.92 Million Investment in Fulgent Genetics, Inc. $FLGT - MarketBeat
Precision Trading with Fulgent Genetics Inc. (FLGT) Risk Zones - Stock Traders Daily
Connor Clark & Lunn Investment Management Ltd. Purchases New Position in Fulgent Genetics, Inc. $FLGT - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Upgraded at Wall Street Zen - MarketBeat
Fulgent Genetics CSO Gao Hanlin sells $18,691 in stock By Investing.com - Investing.com Nigeria
Fulgent Genetics CSO Gao Hanlin sells $18,691 in stock - Investing.com India
Jian Xie Sells 1,193 Shares of Fulgent Genetics (NASDAQ:FLGT) Stock - MarketBeat
Fulgent Genetics COO Xie Jian disposes of $23,747 in company stock - Investing.com
Fulgent Genetics (NASDAQ: FLGT) holder plans tax-driven share sale - Stock Titan
Fulgent Genetics (NASDAQ:FLGT) Insider Hanlin Gao Sells 939 Shares - MarketBeat
Fulgent (FLGT) Technicals: Slides 0.10% to $19.90 at the Close; the Near-Term Reference Band Stretches From $18.90 to $20.89 under the Current SnapshotPrice Action Signals - vinanet.vn
Renaissance Technologies LLC Decreases Stock Position in Fulgent Genetics, Inc. $FLGT - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Share Price Crosses Below Fifty Day Moving AverageHere's What Happened - MarketBeat
Fulgent Genetics details new protocols for variant reclassification and segregation testing recommendations - tradersunion.com
Fulgent Genetics (FLGT) Q2 2026 Earnings Call Transcript - AOL.com
Fulgent Genetics, Inc. $FLGT Shares Purchased by Quantinno Capital Management LP - MarketBeat
Discipline and Rules-Based Execution in FLGT Response - Stock Traders Daily
Fulgent Genetics, Inc. $FLGT Shares Sold by Dimensional Fund Advisors LP - MarketBeat
Wall Street Zen Downgrades Fulgent Genetics (NASDAQ:FLGT) to Strong Sell - MarketBeat
Fulgent Genetics, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:FLGT) 2026-08-07 - Seeking Alpha
Price to sales forward of Fulgent Genetics, Inc. – MUN:7F0 - TradingView
Fulgent Genetics, Inc. (FLGT) Stock Analysis: Navigating a Complicated Financial Landscape in Healthcare - DirectorsTalk Interviews
FLGT Q1 2026 Earnings: EPS Misses by 23.6% Despite Positive Stock ReactionRevenue Breakdown Analysis - vinanet.vn
Fulgent Genetics (FLGT) Stock Gets Fair Value Boost After Analysts Raised Targets - Yahoo Finance
Fulgent Deadline Alert - TMX Newsfile
FLGT Maintained by Piper Sandler -- Price Target Raised to $19.0 - GuruFocus
Piper Sandler Maintains Fulgent Genetics(FLGT.US) With Hold Rating, Cuts Target Price to $19 - Moomoo
Fulgent Genetics Inc (7F0) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
FLGT Q1 2026 Earnings: EPS Misses Estimates by 23.6%, Shares Tumble 18%Pre-Announcement Alert - vinanet.vn
FLGT Q1 2026 Earnings: EPS Misses Estimates by 23.6% as Shares Slide 18%Revenue Miss Report - vinanet.vn
Fulgent Genetics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Fulgent Genetics Inc (FLGT) (Q2 2026) Earnings Call Highlights: Strategic Progress Amid Revenue ... By GuruFocus - Investing.com Canada
Earnings call transcript: Fulgent Genetics cuts 2026 outlook after q2 miss - Investing.com Nigeria
FLGT Looks 16.7% Undervalued on GF Value™ Despite Revenue Miss - GuruFocus
Fulgent Genetics (FLGT) Releases Q2 2026 Earnings: Revenue Growth but EPS Miss - Quiver Quantitative
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022. - marketscreener.com
Fulgent Genetics, Inc. Revises Earnings Guidance for the Year Ending December 31, 2026 - marketscreener.com
Fulgent Genetics cuts FY26 revenue guidance amid billing delays - scanx.trade
Behavioral Patterns of FLGT and Institutional Flows - news.stocktradersdaily.com
Fulgent Genetics CFO Kim Paul Executes Tax-Driven Share Withholding, Sells 2,747 Shares at $19.67 Each - Kalkine Media
Fulgent Genetics Inc (FLGT) Cash Flow - TradingKey
Fulgent Genetics Inc (FLGT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Fulgent Genetics Inc Azioni (FLGT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Fulgent Genetics Inc Azioni (FLGT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Gao Hanlin | Chief Scientific Officer |
Aug 27 '26 |
Sale |
19.91 |
939 |
18,691 |
987,790 |
1.39%
1.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):